Eight versus four induction cycles of Carfilzomib, Thalidomide and Low-dose Dexamethasone: the Carthadex trial

被引:0
|
作者
Wester, Ruth [1 ]
Zweegman, Sonja [2 ]
Van der Holt, Bronno [3 ]
Jose, Kersten Marie [4 ]
Vellenga, Edo [5 ]
van Marwijk-Kooy, Marinus [6 ]
Asselbergs, Emelie [1 ]
de Weerdt, Okke [7 ]
Minnema, Monique [8 ]
Lonergan, Sarah [9 ]
Palumbo, Antonio [10 ]
Broijl, Annemiek [1 ]
Sonneveld, Pieter [1 ]
机构
[1] Erasmus MC, Canc Inst, Rotterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
[3] HOVON Data Ctr, Rotterdam, Netherlands
[4] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[5] Univ Med Ctr Groningen, Groningen, Netherlands
[6] Isala Clin, Zwolle, Netherlands
[7] St Antonius Hosp, Nieuwegein, Netherlands
[8] Univ Med Ctr Utrecht, Utrecht, Netherlands
[9] European Myeloma Network, Rotterdam, Netherlands
[10] Univ Turin, Azienda Osped Univ Citta Salute & Sci Torino, Turin, Italy
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词
survival; Tolerability; treatment;
D O I
10.1016/j.clml.2019.09.367
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SP-041
引用
收藏
页码:E220 / E221
页数:2
相关论文
共 50 条
  • [1] Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial
    Wester, Ruth
    Zweegman, Sonja
    van der Holt, Bronno
    Kersten, Marie Jose
    Vellenga, Edo
    van Marwijk-Kooy, Marinus
    Asselbergs, Emelie
    de Weerdt, Okke
    Minnema, Monique C.
    Lonergan, Sarah
    Palumbo, Antonio
    Broijl, Annemiek
    Sonneveld, Pieter
    HEMASPHERE, 2020, 4 (04):
  • [2] Carfilzomib Combined with Thalidomide and Low-Dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma: The Carthadex Trial
    Wester, Ruth
    van der Holt, Bronno
    Asselbergs, Emelie
    Zweegman, Sonja
    Kersten, Marie Jose
    Vellenga, Edo
    Kooij, Marinus van Marwijk
    de Weerdt, Okke
    Minnema, Monique C.
    Lonergan, Sarah
    Palumbo, Antonio
    Lokhorst, Henk M.
    Broyl, Annemiek
    Iskander, Karim Saad
    Sonneveld, Pieter
    BLOOD, 2017, 130
  • [3] Phase 2 Study of Carfilzomib, Thalidomide, and Low-Dose Dexamethasone As Induction/Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma, the Carthadex Trial
    Wester, Ruth
    van der Holt, Bronno
    Asselbergs, Emelie
    van Duin, Mark
    Zweegman, Sonja
    Kersten, Marie Jose
    Vellenga, Edo
    Kooy, Marinus van Marwijk
    de Weerdt, Okke
    Minnema, Monique
    Lonergan, Sarah
    Palumbo, Antonio
    Lokhorst, Henk M.
    Broijl, Annemiek
    Sonneveld, Pieter
    BLOOD, 2016, 128 (22)
  • [4] Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial
    Wester, Ruth
    van der Holt, Bronno
    Asselbergs, Emelie
    Zweegman, Sonja
    Kersten, Marie Jose
    Vellenga, Edo
    Kooy, Marinus van Marwijk
    de Weerdt, Okke
    Minnema, Monique
    Lonergan, Sarah
    Palumbo, Antonio
    Lokhorst, Henk
    Broijl, Annemiek
    Sonneveld, Pieter
    HAEMATOLOGICA, 2019, 104 (11) : 2265 - 2273
  • [5] Thalidomide and low-dose dexamethasone in myeloma treatment
    Myers, B
    Grimley, C
    Dolan, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 245 - 245
  • [6] Thalidomide with continuous low-dose dexamethasone for multiple myeloma
    Gardyn, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1323 - 1323
  • [7] Phase III trial of thalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 452 - 453
  • [8] Lenalidomide Plus Low-Dose Dexamethasone Compared with Thalidomide Plus Low-Dose Dexamethasone: A Randomised Phase III Study
    Mookerjee, Anjali
    Gupta, Ritu
    Sharma, Atul
    Saikia, Tapan
    Kumar, Lalit
    BLOOD, 2011, 118 (21) : 1264 - 1265
  • [9] Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma
    Murakami, Hirokazu
    Handa, Hiroshi
    Abe, Masahiro
    Iida, Sinsuke
    Ishii, Akihiro
    Ishikawa, Takayuki
    Ishida, Tadao
    Oota, Masatsugu
    Ozaki, Shuji
    Kosaka, Masaaki
    Sakai, Akira
    Sawamura, Morio
    Shimazaki, Chihiro
    Shimizu, Kazuyuki
    Takagi, Toshiyuki
    Hata, Hiroyuki
    Fukuhara, Takashi
    Fujii, Hiroshi
    Miyata, Akira
    Wakayama, Toshio
    Takatsuki, Kiyoshi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (03) : 234 - 239
  • [10] Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone
    Coleman, M
    Leonard, J
    Lyons, L
    Szelenyi, H
    Niesvizky, R
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 270 - 274